The asset management firm is expected to lend about ₹600 crore to facilitate the repurchase of shares from British International Investment (BII) and OrbiMed, which hold the stakes in AIMS' parent entity, Blue Sapphire Healthcare. The deal with 360 ONE is likely to be signed within the next few weeks, the people said.